M. Izmirli, Hasret Ecevit, H. Okuyan, E. Rifaioǧlu
{"title":"异维甲酸治疗寻常痤疮患者8-OHdG和hOGG1氧化DNA损伤标志物的研究","authors":"M. Izmirli, Hasret Ecevit, H. Okuyan, E. Rifaioǧlu","doi":"10.5812/jssc.103492","DOIUrl":null,"url":null,"abstract":"Background: Acne vulgaris is the most common inflammatory skin disease. It is primarily observed in adolescents and is characterized by comedones, papules, pustules, nodules, and cysts on the face, back, chest, chin, and body skin. Acne vulgaris affects about 80% of teenagers and continues beyond the age of 25 years in 3% of men and 12% of women in the world. Isotretinoin is one of themostcommontreatmentagentsforacnevulgaris, whichcausesoxidativeDNAdamageinthecell. Asanimportantindicator of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine is repaired with an enzyme called human 8-oxoguanine DNA glycosylase 1 (hOGG1). Objectives: WeaimedtoevaluateoxidativeDNAdamageinacnevulgarisbeforeandafterisotretinointreatmentbymeasuringthe 8-OHdG and hOGG1 levels. Methods: The8-OHdGandhOGG1levelswereevaluatedfromserumsamplesusingtheenzyme-linkedimmunosorbentassay(ELISA) method. Both the serum 8-OHdG (P < 0.05; P < 0.0001) and hOGG1 (P < 0.05; P = 0.04) levels were found to be statistically higher in the sixth month after isotretinoin treatment. Results: In this first report, the 8-OHdG and hOGG1 levels were found to be statistically significantly high after isotretinoin treatment. According to our results, the 8-OHdG level increased under isotretinoin administration in acne vulgaris patients. Conclusions: Consequently, healing via hOGG1 likely continues after dropping isotretinoin for DNA.","PeriodicalId":174870,"journal":{"name":"Journal of Skin and Stem Cell","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"8-OHdG and hOGG1 as Oxidative DNA Damage Markers in Acne Vulgaris Patients Under Isotretinoin Treatment\",\"authors\":\"M. Izmirli, Hasret Ecevit, H. Okuyan, E. Rifaioǧlu\",\"doi\":\"10.5812/jssc.103492\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Acne vulgaris is the most common inflammatory skin disease. It is primarily observed in adolescents and is characterized by comedones, papules, pustules, nodules, and cysts on the face, back, chest, chin, and body skin. Acne vulgaris affects about 80% of teenagers and continues beyond the age of 25 years in 3% of men and 12% of women in the world. Isotretinoin is one of themostcommontreatmentagentsforacnevulgaris, whichcausesoxidativeDNAdamageinthecell. Asanimportantindicator of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine is repaired with an enzyme called human 8-oxoguanine DNA glycosylase 1 (hOGG1). Objectives: WeaimedtoevaluateoxidativeDNAdamageinacnevulgarisbeforeandafterisotretinointreatmentbymeasuringthe 8-OHdG and hOGG1 levels. Methods: The8-OHdGandhOGG1levelswereevaluatedfromserumsamplesusingtheenzyme-linkedimmunosorbentassay(ELISA) method. Both the serum 8-OHdG (P < 0.05; P < 0.0001) and hOGG1 (P < 0.05; P = 0.04) levels were found to be statistically higher in the sixth month after isotretinoin treatment. Results: In this first report, the 8-OHdG and hOGG1 levels were found to be statistically significantly high after isotretinoin treatment. According to our results, the 8-OHdG level increased under isotretinoin administration in acne vulgaris patients. Conclusions: Consequently, healing via hOGG1 likely continues after dropping isotretinoin for DNA.\",\"PeriodicalId\":174870,\"journal\":{\"name\":\"Journal of Skin and Stem Cell\",\"volume\":\"31 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Skin and Stem Cell\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5812/jssc.103492\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Skin and Stem Cell","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/jssc.103492","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
8-OHdG and hOGG1 as Oxidative DNA Damage Markers in Acne Vulgaris Patients Under Isotretinoin Treatment
Background: Acne vulgaris is the most common inflammatory skin disease. It is primarily observed in adolescents and is characterized by comedones, papules, pustules, nodules, and cysts on the face, back, chest, chin, and body skin. Acne vulgaris affects about 80% of teenagers and continues beyond the age of 25 years in 3% of men and 12% of women in the world. Isotretinoin is one of themostcommontreatmentagentsforacnevulgaris, whichcausesoxidativeDNAdamageinthecell. Asanimportantindicator of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine is repaired with an enzyme called human 8-oxoguanine DNA glycosylase 1 (hOGG1). Objectives: WeaimedtoevaluateoxidativeDNAdamageinacnevulgarisbeforeandafterisotretinointreatmentbymeasuringthe 8-OHdG and hOGG1 levels. Methods: The8-OHdGandhOGG1levelswereevaluatedfromserumsamplesusingtheenzyme-linkedimmunosorbentassay(ELISA) method. Both the serum 8-OHdG (P < 0.05; P < 0.0001) and hOGG1 (P < 0.05; P = 0.04) levels were found to be statistically higher in the sixth month after isotretinoin treatment. Results: In this first report, the 8-OHdG and hOGG1 levels were found to be statistically significantly high after isotretinoin treatment. According to our results, the 8-OHdG level increased under isotretinoin administration in acne vulgaris patients. Conclusions: Consequently, healing via hOGG1 likely continues after dropping isotretinoin for DNA.